Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Fibrosis is the strongest predictor for disease-specific mortality in non-alcoholic fatty liver diseases (NAFLD), but the need for liver biopsy limits its diagnosis. We assessed the performance of plasma ficolin-2 (FCN-2) as a biomarker of fibrosis identified by an in silico discovery strategy. Two...

Full description

Bibliographic Details
Main Authors: Pablo J. Giraudi, Noel Salvoza, Deborah Bonazza, Carlo Saitta, Daniele Lombardo, Biagio Casagranda, Nicolò de Manzini, Teresa Pollicino, Giovanni Raimondo, Claudio Tiribelli, Silvia Palmisano, Natalia Rosso
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
biomarkers
in silico
non-alcoholic fatty liver disease
discovery strategy
omics
blood-based tests
Online Access:https://www.mdpi.com/1422-0067/23/5/2813

Internet

https://www.mdpi.com/1422-0067/23/5/2813

Similar Items